NCT06558825
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women With Trauma-related Conditions
StatusCompleted
PhaseNot applicable
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Study completion date changed from estimate of Jun 30, 2025 to Jun 30, 2026 Show 8 more changesShow less
- Eligibility criteria expanded, about 13 words
- Trial completed
- Final enrollment: 52 participants (planned 60)
- Start date: Oct 1, 2024 to Jun 5, 2023
- Secondary endpoints: details revised at 4 of 11 entries
- Study description expanded, about 150 words
- Site details revised
- Publications: details revised at 1 of 1 entry
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Sep 1, 2024 to Oct 1, 2024
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Number of participants who uptake PrEP
Timeframe: 12 weeks post intervention
Secondary (11)
Number of Participants who adhere to PrEP
PrEP adherence as assessed by proportion of videos uploaded
PrEP adherence as assessed by proportion of self-reported daily adherence
Intervention feasibility as assessed by number of participants enrolled
Intervention feasibility as assessed by number of sessions attended by participants
Show 6 moreShow less
Intervention feasibility as assessed by study retention
Intervention acceptability as assessed by score on a satisfaction questionnaire
Change in PrEP Anticipated Stigma as assessed by the PrEP Anticipated Stigma Scale
Change in perceived HIV risk as assessed by Perceived Risk of HIV Scale
Change in PrEP knowledge as assessed by PrEP Knowledge Questionnaire
Change in PrEP attitudes as assessed by PrEP Attitudes Measure
Arms and interventions
Integrated Intervention to Promote PrEP UptakeExperimental
Standard Treatment ConditionActive comparator
Behavioral: Integrated Intervention to Promote PrEP Uptake
Other: Standard Treatment Condition
Sites
1 site in 1 country
- Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at HoustonHouston, Texas, United States